[Table/Fig-5]:

Mean CSF enzymes in relation to outcome in TBM. *Deteriorated means those who develop focal neurologic deficit or cranial nerve palsy or seizures

CSF Enzyme	Patient improved (n=06)		p-value	Patient deteriorated* (n=03)		p-value	Patient who died (n=03)
	0th day 0	7th Day		0th day 0	7th Day		0th day 0	7th Day
CK(U/l)	49.54 ± 20.2	27.3 ± 10.4	<0.0001	54.3 ± 21.1	25.12 ± 6.0	<0.005	66.5 ± 9.19	Not done
LDH(U/l)	192.9 ± 65.52	111.5 ± 42	<0.0001	187 ± 61.65	102.3 ± 34.81	<0.005	325 ± 141.4	Not done
GGTP(U/l)	21.22 ± 10.24	19 ± 3.5	0.345	15.6 ± 4.06	16.37 ± 3.37	=0.497	17 ± 1.41	Not done